09-11, 17:30–18:00 (Europe/Istanbul), Head & Neck Oncology 4
Session Chair
Session Chair
Speaker
Speaker
<p>Graduated from Hacettepe University Faculty of Medicine in 2000. He completed his ENT&HNS education at ENT Department of Gazi University Faculty of Medicine and has been working as a faculty member in the same clinic in the field of head and neck surgery since 2011. His main fields of study are Larynx cancers, salivary gland tumors and neck masses. He has published more than 80 articles and has an h-index of 16.</p>
This speaker also appears in:
- Salivary gland tumors: modern approach from diagnosis to treatment
- Redefining Prognosis: Long-Term Outcomes of TORS for Hypopharyngeal and Laryngeal Cancers
- 20 Years of Supratracheal Laryngectomy: A Comprehensive Review and Future Perspectives
- Management of intermediate and advanced laryngeal cancer (T3-T4)
<p>Jaiganesh Manickavasagam (Jai Manick) is a distinguished Consultant Head and Neck Surgeon and clinical leader with over 13 years of senior experience. He currently holds several pivotal leadership roles, including Clinical Director for Cancer Services at NHS Tayside and Lead for Head and Neck Surgery at Ninewells Hospital. His career is characterized by a unique fusion of high-volume clinical expertise, academic innovation, and national governance.</p>
<p>At the University of Dundee, he is the Founder and Director of the MCh Head and Neck Surgery program. This prestigious degree attracts surgeons globally, establishing a world-class curriculum for advanced surgical training. Complementing this, he serves as the Director of the Dundee Institute of Head and Neck Education (DIHNE). In this capacity, he leads the educational strategy for one of the UK’s premier training hubs, personally conducting nine annual hands-on cadaveric courses that provide essential technical training to the global ENT community.</p>
<p>A pioneer in surgical technology, Jai Manick has surpassed the 100-case milestone in Transoral Robotic Surgery (TORS). His series is notably distinct from standard datasets; while it covers tongue base and tonsil tumors, it places a heavy emphasis on complex oncological resections and rare "post-malignancy" pharyngeal cases. This extensive experience allows him to provide an evidence-based perspective on the entire patient journey—from multidisciplinary team (MDT) planning and robotic simulation to the management of complex complications and long-term functional outcomes.</p>
<p>His influence extends to the highest levels of professional governance. He is the Secretary of the ENTUK Head and Neck Council and the Assistant Secretary for ENT Scotland. These roles involve shaping national clinical standards and representing the specialty in major strategic forums. His organizational prowess is further evidenced by his role as the lead organizer for eight international conferences, which have successfully hosted over 8,000 national and international delegates, fostering a global exchange of surgical knowledge.</p>
<p>An active researcher, he holds a Diploma in Clinical Trials from the University of Edinburgh and has served as the Principal Investigator (PI) for 14 national research projects. His work includes ground-breaking studies such as the first UK gene therapy trial for salivary glands. His academic reach is truly international, maintaining robust collaborations and visiting professorships across India, Egypt, and Germany.</p>
<p>By combining his roles as a high-volume robotic surgeon, a visionary educator at DIHNE, and a key figure in ENTUK governance, Jai Manick remains at the forefront of the specialty. He is dedicated to "Serving Tomorrow’s World Today" by integrating advanced robotics, translational research, and multidisciplinary excellence into the global surgical landscape.</p>
This speaker also appears in: